Genmab AS Stock Forecast - Naive Prediction
| GMAB Stock | USD 20.65 0.18 0.88% |
The Naive Prediction forecasted value of Genmab AS on the next trading day is expected to be 20.06 with a mean absolute deviation of 0.33 and the sum of the absolute errors of 20.00. Genmab Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Genmab AS stock prices and determine the direction of Genmab AS's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Genmab AS's historical fundamentals, such as revenue growth or operating cash flow patterns.
Genmab |
Genmab AS Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Genmab AS's financial statements to predict how it will affect future prices.
Cash | First Reported 2009-12-31 | Previous Quarter 4.3 B | Current Value 6.3 B | Quarterly Volatility 4.5 B |
Genmab AS Naive Prediction Price Forecast For the 26th of November
Given 90 days horizon, the Naive Prediction forecasted value of Genmab AS on the next trading day is expected to be 20.06 with a mean absolute deviation of 0.33, mean absolute percentage error of 0.17, and the sum of the absolute errors of 20.00.Please note that although there have been many attempts to predict Genmab Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Genmab AS's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Genmab AS Stock Forecast Pattern
| Backtest Genmab AS | Genmab AS Price Prediction | Buy or Sell Advice |
Genmab AS Forecasted Value
In the context of forecasting Genmab AS's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Genmab AS's downside and upside margins for the forecasting period are 18.60 and 21.52, respectively. We have considered Genmab AS's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Genmab AS stock data series using in forecasting. Note that when a statistical model is used to represent Genmab AS stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.3531 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.3279 |
| MAPE | Mean absolute percentage error | 0.014 |
| SAE | Sum of the absolute errors | 20.0031 |
Predictive Modules for Genmab AS
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genmab AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Genmab AS
For every potential investor in Genmab, whether a beginner or expert, Genmab AS's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Genmab Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Genmab. Basic forecasting techniques help filter out the noise by identifying Genmab AS's price trends.Genmab AS Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genmab AS stock to make a market-neutral strategy. Peer analysis of Genmab AS could also be used in its relative valuation, which is a method of valuing Genmab AS by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Genmab AS Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Genmab AS's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Genmab AS's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Genmab AS Market Strength Events
Market strength indicators help investors to evaluate how Genmab AS stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genmab AS shares will generate the highest return on investment. By undertsting and applying Genmab AS stock market strength indicators, traders can identify Genmab AS entry and exit signals to maximize returns.
Genmab AS Risk Indicators
The analysis of Genmab AS's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Genmab AS's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting genmab stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.12 | |||
| Standard Deviation | 1.48 | |||
| Variance | 2.19 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:Check out Historical Fundamental Analysis of Genmab AS to cross-verify your projections. For information on how to trade Genmab Stock refer to our How to Trade Genmab Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genmab AS. If investors know Genmab will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genmab AS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.38) | Earnings Share 1.02 | Revenue Per Share 30.6997 | Quarterly Revenue Growth 0.176 | Return On Assets 0.1095 |
The market value of Genmab AS is measured differently than its book value, which is the value of Genmab that is recorded on the company's balance sheet. Investors also form their own opinion of Genmab AS's value that differs from its market value or its book value, called intrinsic value, which is Genmab AS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genmab AS's market value can be influenced by many factors that don't directly affect Genmab AS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genmab AS's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genmab AS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genmab AS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.